Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Breast Cancer · Non-small Cell Lung Cancer (NSCLC) · Gastric/Gastroesophageal Junction (GEJ) Cancer · Bladder Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Novartis Investigative Site, Darlinghurst, New South Wales, Australia
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Kashiwa, Chiba, Japan

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada

Cancer · Prostate Cancers · Breast Cancers

Abroad (travel likely)Recruiting

Calgary, Canada · Vancouver, Canada

Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment

Cancer

Abroad (travel likely)Recruiting

Los Angeles, United States

Phase I Human Analytics (HALO) Study

Cardiovascular Diseases · Cancer · Dementia

Abroad (travel likely)Recruiting

Indian Wells, United States

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

High Grade Epithelial Ovarian Cancer · High Grade Serous Ovarian Cancer · Primary Peritoneal Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Phoenix, United States · Tucson, United States